This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human HB-EGF DuoSet ELISA
catalog :
DY259B
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 20
Reference
Shumliakivska M, Lux xe1 n G, Hemmerling I, Scheller M, Li X, M xfc ller Tidow C, et al. DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts. Nat Commun. 2024;15:606 pubmed publisher
Rogmans C, Kuhlmann J, Hugendieck G, Link T, Arnold N, Weimer J, et al. ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer. Cancers (Basel). 2021;13: pubmed publisher
Zhu G, Liu J, Wang Y, Jia N, Wang W, Zhang J, et al. ADAM17 Mediates Hypoxia-Induced Keratinocyte Migration via the p38/MAPK Pathway. Biomed Res Int. 2021;2021:8328216 pubmed publisher
O Sullivan M, Jang J, Panariti A, Bedrat A, Ijpma G, Lemos B, et al. Airway Epithelial Cells Drive Airway Smooth Muscle Cell Phenotype Switching to the Proliferative and Pro-inflammatory Phenotype. Front Physiol. 2021;12:687654 pubmed publisher
Wang S, Li R, Ng T, Luthria G, Oudin M, Prytyskach M, et al. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020;6:eaaz8521 pubmed publisher
Chatterjee K, Jana S, DasMahapatra P, Swarnakar S. EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression. FASEB J. 2018;32:4560-4572 pubmed publisher
Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, et al. BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study. BMC Cancer. 2017;17:89 pubmed publisher
Kefaloyianni E, Muthu M, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, et al. ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight. 2016;1: pubmed publisher
Hoffmann F, Hofereiter J, Rübsamen H, Melms J, Schwarz S, Faber H, et al. Fingolimod induces neuroprotective factors in human astrocytes. J Neuroinflammation. 2015;12:184 pubmed publisher
Dombernowsky S, Samsøe Petersen J, Petersen C, Instrell R, Hedegaard A, Thomas L, et al. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17. Nat Commun. 2015;6:7518 pubmed publisher
Li L, Chakraborty S, Yang C, Hatanpaa K, Cipher D, Puliyappadamba V, et al. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII. Oncogene. 2014;33:4253-64 pubmed publisher
Richards F, Tape C, Jodrell D, Murphy G. Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS ONE. 2012;7:e40597 pubmed publisher
Hikita S, Yotsumoto F, Fukami T, Fumaki T, Horiuchi S, Sanui A, et al. Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA. Anticancer Res. 2011;31:2553-9 pubmed
Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev I, et al. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin Cancer Res. 2011;17:3619-30 pubmed publisher
Murthy A, Defamie V, Smookler D, Di Grappa M, Horiuchi K, Federici M, et al. Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest. 2010;120:2731-44 pubmed publisher
Mulder G, Nijboer W, Seelen M, Sandovici M, Bos E, Melenhorst W, et al. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury. J Pathol. 2010;221:183-92 pubmed publisher
Egloff A, Rothstein M, Seethala R, Siegfried J, Grandis J, Stabile L. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15:6529-40 pubmed publisher
Tohyama M, Hanakawa Y, Shirakata Y, Dai X, Yang L, Hirakawa S, et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur J Immunol. 2009;39:2779-88 pubmed publisher
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed
Schnapp L, Donohoe S, Chen J, Sunde D, Kelly P, Ruzinski J, et al. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol. 2006;169:86-95 pubmed
product information
master code :
DY259B
SKU :
DY259B
product name :
Human HB-EGF DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human HB-EGF DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human HB-EGF.
target :
HB-EGF
category :
ELISAs
species :
Human
gene symbol :
HBEGF
kit type :
Solid Phase Sandwich ELISA
elisaRange :
7.81 - 500 pg/mL
top caption :
Human HB-EGF ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
diphtheria toxin receptor (heparin-binding epidermal growth factor-like growthfactor), Dtr, DTRHEGFLdiphtheria toxin receptor (heparin-binding EGF-like growth factor), Dts, DTSF, HBEGF, Hegfl, heparin-binding EGF-like growth factor, heparin-binding epidermal growth factor, proheparin-binding EGF-like growth factor
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.